Marc N Wagner

Marc Wagner focuses his practice on regulatory and transactional matters, primarily in the healthcare and life sciences industries. He has experience advising clients on Food and Drug Administration (FDA) regulatory matters, including food, drug, device, dietary supplement and cosmetic issues, as well as matters related to compounding pharmacies operating pursuant to Section 503A of the Federal Food, Drug and Cosmetic Act (FD&C Act) and outsourcing facilities operating pursuant to Section 503B of the FD&C Act.

Marc also has experience assisting clients with matters related to Drug Enforcement Administration (DEA) compliance. In addition, he helps drug manufacturer, pharmacy, wholesaler and third-party logistics provider clients navigate state licensing, pharmacy practice and drug control act issues.

Marc’s educational and professional background as a registered pharmacist provides him with a substantial understanding of a variety of pharmaceutical compliance measures. This background enables him to assist with life science transactions and navigate federal and state licensing for human and veterinary drug manufacturers, wholesale distributors, pharmacies and outsourcing facilities.

American Society for Pharmacy Law (2019 to present)

End Drug Shortages Alliance (2024 to present)

Food and Drug Law Institute

-- Veterinary Products Task Force (2025-present)

-- Publications Peer Review Committee (2023-2024)

-- New to Food and Drug Law (NFDL) Planning Committee (2021-2022)